Hiroaki Ida Selected Research

HLA-DRB1*04:05 antigen

11/2007	Bone edema determined by magnetic resonance imaging reflects severe disease status in patients with early-stage rheumatoid arthritis.
8/2006	Evidence for the role of small ubiquitin-like modifier 4 as a general autoimmunity locus in the Japanese population.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiroaki Ida Research Topics

Disease

30	Rheumatoid Arthritis 08/2021 - 02/2004
7	Inflammation (Inflammations) 10/2015 - 02/2004
6	Fever (Fevers) 10/2022 - 03/2009
6	Arthritis (Polyarthritis) 12/2015 - 03/2009
6	Systemic Lupus Erythematosus (Libman-Sacks Disease) 03/2014 - 01/2004
5	Edema (Dropsy) 10/2022 - 11/2007
5	Dermatomyositis (Dermatopolymyositis) 03/2022 - 08/2006
5	Interstitial Lung Diseases (Interstitial Lung Disease) 04/2018 - 08/2006
4	Melanoma (Melanoma, Malignant) 03/2022 - 01/2015
4	Synovitis 09/2012 - 02/2004
2	Fibrosis (Cirrhosis) 10/2022 - 07/2022
2	Thrombocytopenia (Thrombopenia) 10/2022 - 01/2020
2	Polymyositis 03/2022 - 10/2010
2	Vasculitis (Vasculitides) 01/2021 - 01/2006
2	Disease Progression 01/2020 - 01/2005
2	Hemoptysis 03/2015 - 07/2007
2	Macrophage Activation Syndrome 01/2015 - 04/2013
2	Infections 07/2011 - 01/2007
2	Disease Susceptibility (Diathesis) 06/2011 - 08/2010
2	Osteoarthritis 03/2011 - 02/2004
2	Hemorrhage 06/2009 - 07/2007
2	Tropical Spastic Paraparesis (Tropical Spastic Paraplegia) 01/2009 - 01/2008
2	Liver Diseases (Liver Disease) 01/2007 - 01/2004
2	Polyarteritis Nodosa (Periarteritis Nodosa) 04/2006 - 01/2006
2	Autoimmune Diseases (Autoimmune Disease) 01/2005 - 12/2003
1	Multi-centric Castleman's Disease 10/2022
1	Sialadenitis 07/2022
1	Myalgia 09/2021
1	Lymphoma (Lymphomas) 01/2020
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2020
1	Skin Diseases (Skin Disease) 01/2020
1	Amyloidosis 01/2020
1	Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis) 06/2018
1	Idiopathic Interstitial Pneumonias 04/2018
1	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 01/2017
1	Meningitis 01/2017
1	Bronchiectasis 11/2016
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2015
1	Amyopathic dermatomyositis 01/2015
1	Arteritis 09/2014
1	Schnitzler Syndrome 07/2014
1	Ulcer 03/2014
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 04/2013
1	Arthralgia (Joint Pain) 01/2013

Drug/Important Bio-Agent (IBA)

9	AutoantibodiesIBA 12/2015 - 12/2003
8	Prednisolone (Predate)FDA LinkGeneric 10/2022 - 01/2004
8	AntibodiesIBA 01/2016 - 09/2003
8	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2012 - 01/2002
5	SteroidsIBA 04/2018 - 01/2006
5	Anti-Citrullinated Protein AntibodiesIBA 03/2013 - 01/2006
5	Immunoglobulin M (IgM)IBA 03/2013 - 01/2006
5	Tumor Necrosis Factor InhibitorsIBA 04/2012 - 02/2010
5	EnzymesIBA 03/2011 - 12/2003
4	Antirheumatic Agents (DMARD)IBA 01/2020 - 07/2011
4	Methotrexate (Mexate)FDA LinkGeneric 01/2020 - 01/2006
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2018 - 01/2010
4	Biomarkers (Surrogate Marker)IBA 01/2015 - 03/2011
4	Cyclosporine (Ciclosporin)FDA LinkGeneric 07/2014 - 08/2006
4	Tacrolimus (Prograf)FDA LinkGeneric 03/2014 - 07/2007
4	Rheumatoid FactorIBA 03/2013 - 01/2006
4	Etanercept (Enbrel)FDA Link 06/2011 - 01/2009
3	Interleukin-6 (Interleukin 6)IBA 10/2022 - 11/2007
3	C-Reactive ProteinIBA 01/2020 - 11/2007
3	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2017 - 07/2007
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2017 - 08/2006
3	GadoliniumIBA 09/2012 - 06/2009
3	Peptides (Polypeptides)IBA 06/2011 - 01/2009
3	cyclic citrullinated peptideIBA 06/2009 - 01/2006
3	DNA (Deoxyribonucleic Acid)IBA 01/2007 - 01/2006
2	Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA 03/2022 - 01/2017
2	Colchicine FDA LinkGeneric 09/2021 - 09/2014
2	Transfer RNA (tRNA)IBA 08/2021 - 12/2003
2	PyrinIBA 01/2020 - 01/2008
2	Peroxidase (Myeloperoxidase)IBA 01/2017 - 07/2007
2	Immunosuppressive Agents (Immunosuppressants)IBA 11/2016 - 03/2014
2	Biological ProductsIBA 12/2015 - 01/2010
2	Proteins (Proteins, Gene)FDA Link 10/2015 - 05/2015
2	InterferonsIBA 01/2015 - 03/2011
2	CytokinesIBA 01/2015 - 02/2004
2	Pharmaceutical PreparationsIBA 06/2012 - 04/2011
2	Adalimumab (Humira)FDA Link 02/2012 - 09/2011
2	tocilizumab (atlizumab)FDA Link 04/2011 - 02/2010
2	Interleukin-18 (Interleukin 18)IBA 03/2011 - 02/2004
2	ImmunosorbentsIBA 03/2011 - 12/2003
2	mizoribineIBA 12/2010 - 01/2010
2	Cartilage Oligomeric Matrix ProteinIBA 10/2010 - 06/2009
2	Infliximab (Remicade)FDA Link 02/2010 - 01/2006
2	HLA-DRB1*04:05 antigenIBA 11/2007 - 08/2006
2	GlucocorticoidsIBA 01/2006 - 01/2006
1	Reticulin (Reticular Fiber)IBA 10/2022
1	CollagenIBA 07/2022
1	Transforming Growth Factors (Transforming Growth Factor)IBA 07/2022
1	transcriptional intermediary factor 1IBA 03/2022
1	Rituximab (Mabthera)FDA Link 01/2021
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 01/2020
1	Interferon Type IIBA 01/2015
1	Ferritins (Ferritin)IBA 01/2015

Therapy/Procedure

13	Therapeutics 04/2018 - 01/2006
2	Plasmapheresis 01/2015 - 01/2006
1	Traction 11/2016